Low expression of NEDD4L was associated with dismal prognosis in ccRCC, suggesting that NEDD4L could act as a prognostic biomarker and therapeutic target in ccRCC (72). The gene discussed is NEDD4L; the disease is nonpapillary renal cell carcinoma.